Radioactive Tracer Market, By Type, By Application, By End User, By Geography

Description

Radioactive Tracer Market is estimated to be valued at USD 4.00 Bn in 2026 and is expected to reach USD 6.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.00 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.40%	2033 Value Projection:	USD 6.59 Bn

The global radioactive tracer market covers a broad set of type categories, including Diagnostic Radioactive Tracers, and Therapeutic Radioactive Tracers, used across applications such as Oncology, Cardiology, and Neurology. Demand is supported by adoption among Hospitals, and Specialty Clinics and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.

Market Dynamics:

Growing adoption across Oncology, and Cardiology, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global radioactive tracer market. A wider range of available options is making these solutions accessible to a broader base of users.

For instance, companies are expanding their portfolios to address evolving requirements across Hospitals, and Specialty Clinics. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global radioactive tracer market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include PerkinElmer Inc., Cardinal Health, Bracco, NTP Radioisotopes, Nordion (Canada) Inc., Curium, IRE, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes, LLC, Lantheus Holdings, Inc., Eckert & Ziegler, Siemens Healthineers, GE Healthcare, Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., and Sumitomo Heavy Industries, Ltd, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market.

Detailed Segmentation:

Global Radioactive Tracer Market, By Type (Revenue, USD Bn, 2021 - 2033)
Diagnostic Radioactive Tracers
Therapeutic Radioactive Tracers
Others
Global Radioactive Tracer Market, By Application (Revenue, USD Bn, 2021 - 2033)
Oncology
Cardiology
Neurology
Thyroid
Orthopedic
Endocrinology
Others
Global Radioactive Tracer Market, By End User (Revenue, USD Bn, 2021 - 2033)
Hospitals
Specialty Clinics
Diagnostic Centers
Academic & Research Institutes
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
PerkinElmer Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Cardinal Health
Bracco
NTP Radioisotopes
Nordion (Canada) Inc.
Curium
IRE
Telix Pharmaceuticals Limited
NorthStar Medical Radioisotopes, LLC
Lantheus Holdings, Inc.
Eckert & Ziegler
Siemens Healthineers
GE Healthcare
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI6389

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market, Radioactive Tracer, By Type
- Market Radioactive Tracer, By Application
- Market Radioactive Tracer, By End User
- Market Radioactive Tracer, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of chronic diseases
- Short half-life of radiopharmaceuticals
- Emerging applications in oncology
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Radioactive Tracer Market, By Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostic Radioactive Tracers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Therapeutic Radioactive Tracers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

5. Global Radioactive Tracer Market, By Application, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

6. Global Radioactive Tracer Market, By End User, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Others
- Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Radioactive Tracer Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,( US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bracco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NTP Radioisotopes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nordion (Canada) Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Curium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IRE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NorthStar Medical Radioisotopes, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eckert & Ziegler
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Nuclear Medicine LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Jubilant DraxImage Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sumitomo Heavy Industries, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us